Sep 23, 2026 9 0
Uploaded by Nguyễn Văn Học
Favorite
Share
More Options
9
Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10)_Page 1

Open in WPS to view all 9 pages